Amer Johnny, Goldfarb Ada, Rachmilewitz Eliezer A, Fibach Eitan
Department of Hematology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
Phytother Res. 2008 Jun;22(6):820-8. doi: 10.1002/ptr.2379.
Many aspects of the pathology in beta-hemoglobinopathies (beta-thalassemia and sickle cell anemia) are mediated by oxidative stress. Fermented papaya preparation (FPP) was tested for its antioxidant effects: the scavenging effect was determined spectrofluorometrically in a cell-free system using 2'-7'-dichlorofluorescin-diacetate (DCF). Both spontaneous and H(2)O(2)-induced DCF oxidations were decreased by FPP in a dose-dependent fashion. Using flow cytometry, it was shown that in vitro treatment of blood cells from beta-thalassemic patients with FPP increased the glutathione content of red blood cells (RBC), platelets and polymorphonuclear (PMN) leukocytes, and reduced their reactive oxygen species, membrane lipid peroxidation and externalization of phosphatidylserine. These effects result in (a) reduced thalassemic RBC sensitivity to hemolysis and phagocytosis by macrophages; (b) improved PMN ability to generate oxidative burst - an intracellular mechanism of bacteriolysis, and (c) reduced platelet tendency to undergo activation, as reflected by fewer platelets carrying external phosphatidylserine. Oral administration of FPP to beta-thalassemic mice (50 mg/mouse/day for 3 months) and to patients (3 g x 3 times/day for 3 months), reduced all the above mentioned parameters of oxidative stress (p < 0.001 in mice and p < 0.005 in patients). These results suggest that FPP, as a potent antioxidant, might alleviate symptoms associated with oxidative stress in severe forms of thalassemia.
β-珠蛋白生成障碍性贫血(β-地中海贫血和镰状细胞贫血)病理过程的许多方面都由氧化应激介导。对发酵木瓜制品(FPP)的抗氧化作用进行了测试:在无细胞体系中使用2'-7'-二氯荧光素二乙酸酯(DCF)通过荧光分光光度法测定其清除作用。FPP以剂量依赖方式降低了自发的和H₂O₂诱导的DCF氧化。使用流式细胞术表明,用FPP体外处理β-地中海贫血患者的血细胞可增加红细胞(RBC)、血小板和多形核(PMN)白细胞的谷胱甘肽含量,并降低其活性氧、膜脂质过氧化和磷脂酰丝氨酸的外化。这些作用导致:(a)降低地中海贫血RBC对巨噬细胞溶血和吞噬作用的敏感性;(b)改善PMN产生氧化爆发的能力——一种细菌溶解的细胞内机制,以及(c)降低血小板活化的倾向,这表现为携带外部磷脂酰丝氨酸的血小板减少。给β-地中海贫血小鼠口服FPP(50mg/小鼠/天,持续3个月)以及给患者口服FPP(3g×3次/天,持续3个月),降低了上述所有氧化应激参数(小鼠中p<0.001,患者中p<0.005)。这些结果表明,FPP作为一种强效抗氧化剂,可能减轻重度地中海贫血中与氧化应激相关的症状。